{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:58:07Z","timestamp":1712336287395},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,6]]},"DOI":"10.7759\/cureus.16963","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T03:12:20Z","timestamp":1628305940000},"source":"Crossref","is-referenced-by-count":2,"title":["Insights on the Impact of External and Internal Boosting on Varicella-Zoster Virus Reactivation Based on Evidence From the First Decade of the United States Universal Varicella Vaccination Program"],"prefix":"10.7759","author":[{"given":"Gary S","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson RE","year":"1965","unstructured":"Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965, 58:9-20.","journal-title":"Proc R Soc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.200","article-title":"Immunologic evidence of reinfection with varicella-zoster virus","volume":"148","author":"Arvin AM","year":"1983","unstructured":"Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis. 1983, 148:200-5. 10.1093\/infdis\/148.2.200","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson M","year":"2002","unstructured":"Brisson M, Gay NJ, Edmunds W J, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002, 20:2500-2507. 10.1016\/s0264-410x","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.2.450","article-title":"The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox","volume":"173","author":"Gershon AA","year":"1996","unstructured":"Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996, 173:450-3. 10.1093\/infdis\/173.2.450","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.023","article-title":"Contacts with children and young people and adult risk of suffering herpes zoster","volume":"29","author":"Salleras M","year":"2011","unstructured":"Salleras M, Dom\u00ednguez A, Soldevila N, et al.. Contacts with children and young people and adult risk of suffering herpes zoster. Vaccine. 2011, 29:7602-5. 10.1016\/j.vaccine.2011.08.023","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(98)70207-5","article-title":"Lasting immunity to varicella in doctors study (L.I.V.I.D. study)","volume":"38","author":"Solomon BA","year":"1998","unstructured":"Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J Am Acad Dermatol. 1998, 38:763-5. 10.1016\/s0190-9622(98)70207-5","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.69.908","article-title":"Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster [article in Japanese]","volume":"69","author":"Terada K","year":"1995","unstructured":"Terada K, Hiraga Y, Kawano S, Kataoka N. Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster [article in Japanese]. Kansenshogaku Zasshi. 1995, 69:908-12. 10.11150\/kansenshogakuzasshi1970.69.908","journal-title":"Kansenshogaku Zasshi"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas SL","year":"2002","unstructured":"Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002, 360:678-82. 10.1016\/S0140-6736(02)09837-9","journal-title":"Lancet"},{"key":"ref9","unstructured":"Food and Drug Administration. Summary for basis of approval. Merck & Co., Varicella Virus Vaccine Live, VARIVAX\u00ae. (1995). Accessed: August 6, 2021: https:\/\/wayback.archive-it.org\/7993\/20170404184220\/https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/Appr...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(95)70106-0","article-title":"Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine","volume":"127","author":"Krause PR","year":"1995","unstructured":"Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr. 1995, 127:518-525. 10.1016\/s0022-3476(95)70106-0","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu TA","year":"1994","unstructured":"Lieu TA, Cochi SL, Black SB, et al.. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994, 271:375-81. 10.1001\/jama.1994.03510290057037","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue JG","year":"1995","unstructured":"Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995, 155:1605-9. 10.1001\/archinte.1995.00430150071008","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(03)00461-4","article-title":"Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance","volume":"21","author":"Goldman GS","year":"2003","unstructured":"Goldman GS. Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance. Vaccine. 2003, 21:4238-42. 10.1016\/s0264-410x(03)00461-4","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.050","article-title":"Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data","volume":"31","author":"Goldman GS","year":"2013","unstructured":"Goldman GS, King PG. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine. 2013, 31:1680-94. 10.1016\/j.vaccine.2012.05.050","journal-title":"Vaccine"},{"key":"ref15","article-title":"Annual summary, Antelope Valley Varicella Active Surveillance Project (VASP), Los Angeles County Department of Health Services (LADHS); Centers for Disease Control and Prevention (CDC)","author":"Maupin T","year":"2002","unstructured":"Maupin T, Goldman GS, Peterson C, Mascola L. Annual summary, Antelope Valley Varicella Active Surveillance Project (VASP), Los Angeles County Department of Health Services (LADHS); Centers for Disease Control and Prevention (CDC). Cooperative Agreement No. U66\/CCU911165-10. 2002,","journal-title":"Cooperative Agreement No. U66\/CCU911165-10"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.1.12","article-title":"Capture-recapture methods--useful or misleading?","volume":"30","author":"Tilling K","year":"2001","unstructured":"Tilling K. Capture-recapture methods--useful or misleading?. Int J Epidemiol. 2001, 30:12-4. 10.1093\/ije\/30.1.12","journal-title":"Int J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003","volume":"5","author":"Yih WK","year":"2005","unstructured":"Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health. 2005, 5:68. 10.1186\/1471-2458-5-68","journal-title":"BMC Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/10915810591000659","article-title":"Universal varicella vaccination: efficacy trends and effect on herpes zoster","volume":"24","author":"Goldman GS","year":"2005","unstructured":"Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol. 2005, 24:205-13. 10.1080\/10915810591000659","journal-title":"Int J Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001249","article-title":"Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010","volume":"35","author":"Civen R","year":"2016","unstructured":"Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L, Bialek SR. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016, 35:1132-6. 10.1097\/INF.0000000000001249","journal-title":"Pediatr Infect Dis J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a90b16","article-title":"The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination","volume":"28","author":"Civen R","year":"2009","unstructured":"Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009, 28:954-9. 10.1097\/INF.0b013e3181a90b16","journal-title":"Pediatr Infect Dis J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181acf84f","article-title":"Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008","volume":"28","author":"Tseng HF","year":"2009","unstructured":"Tseng HF, Smith N, Marcy SM, Sy LS, Jacobsen SJ. Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008. Pediatr Infect Dis J. 2009, 28:1069-72. 10.1097\/INF.0b013e3181acf84f","journal-title":"Pediatr Infect Dis J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(03)00459-6","article-title":"Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage","volume":"21","author":"Goldman GS","year":"2003","unstructured":"Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine. 2003, 21:4243-4249. 10.1016\/s0264-410x(03)00459-6","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(03)00458-4","article-title":"Using capture-recapture methods to assess varicella incidence in a community under active surveillance","volume":"21","author":"Goldman GS","year":"2003","unstructured":"Goldman GS. Using capture-recapture methods to assess varicella incidence in a community under active surveillance. Vaccine. 2003, 21:4250-5. 10.1016\/s0264-410x(03)00458-4","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.064","article-title":"Scientific commentary","volume":"22","author":"Jumaan A","year":"2004","unstructured":"Jumaan A, Schmid DS, Gargiullo P, Seward J. Scientific commentary. Vaccine. 2004, 22:3228-31. 10.1016\/j.vaccine.2004.03.064","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.07.001","article-title":"Response to Letter to the Editor by Jumaan: Goldman's role in the Varicella Active Surveillance Project","volume":"22","author":"Goldman GS","year":"2004","unstructured":"Goldman GS. Response to Letter to the Editor by Jumaan: Goldman's role in the Varicella Active Surveillance Project. Vaccine. 2004, 22:3232-36. 10.1016\/j.vaccine.2004.07.001","journal-title":"Vaccine"},{"key":"ref26","article-title":"Out of the Crisis","author":"Deming WE","year":"1991","unstructured":"Deming WE. Out of the Crisis. MIT-CAES, Cambridge, MA; 1991[1986]."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116400","article-title":"The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies","volume":"135","author":"Hook EB","year":"1992","unstructured":"Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992, 135:1060-7. 10.1093\/oxfordjournals.aje.a116400","journal-title":"Am J Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/22.3.559","article-title":"Ascertainment corrected rates: applications of capture-recapture methods","volume":"22","author":"McCarty DJ","year":"1993","unstructured":"McCarty DJ, Tull ES, Moy CS, Kwoh CK, LaPorte RE. Ascertainment corrected rates: applications of capture-recapture methods. Int J Epidemiol. 1993, 22:559-65. 10.1093\/ije\/22.3.559","journal-title":"Int J Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036021","article-title":"Public health surveillance in the United States","volume":"10","author":"Thacker SB","year":"1988","unstructured":"Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev. 1988, 10:164-90. 10.1093\/oxfordjournals.epirev.a036021","journal-title":"Epidemiol Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995-2000","volume":"287","author":"Seward JF","year":"2002","unstructured":"Seward JF, Watson BM, Peterson CL, et al.. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002, 287:606-11. 10.1001\/jama.287.5.606","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study","volume":"292","author":"Seward JF","year":"2004","unstructured":"Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004, 292:704-8. 10.1001\/jama.292.6.704","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.12.1136","article-title":"Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001","volume":"159","author":"Zhou F","year":"2005","unstructured":"Zhou F, Santoli J, Messonnier ML, et al.. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med. 2005, 159:1136-44. 10.1001\/archpedi.159.12.1136","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06180-x","article-title":"Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study","volume":"21","author":"Bianchi FP","year":"2021","unstructured":"Bianchi FP, Tafuri S, Larocca AM, Germinario CA, Stefanizzi P. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study. BMC Infect Dis. 2021, 21:475. 10.1186\/s12879-021-06180-x","journal-title":"BMC Infect Dis"},{"key":"ref34","article-title":"Potential changes in zoster epidemiology with childhood immunization","author":"Edmunds J","year":"2002","unstructured":"Edmunds J, Brisson M. Potential changes in zoster epidemiology with childhood immunization. 42nd Interscience Conference on Antimicrobial Agents and Chemotherappy (ICAAC). ICAAC, San Diego, California; 2002."},{"key":"ref35","article-title":"Surveillance of viral pathogens in Australia--varicella-zoster virus","volume":"26","author":"Roche P","year":"2002","unstructured":"Roche P, Blumer C, Spencer J. Surveillance of viral pathogens in Australia--varicella-zoster virus. Commun Dis Intell Q Rep. 2002, 26:576-80.","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref36","article-title":"Treatment of congestive heart failure","volume":"287","author":"Stevenson LW","year":"2002","unstructured":"Stevenson LW. Treatment of congestive heart failure. JAMA. 2002, 287:2209-10.","journal-title":"JAMA"},{"key":"ref37","article-title":"The Incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factors Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2000","author":"Yih WK","year":"2003","unstructured":"Yih WK, Brooks DR, Clements KM, Lett SM, Jumaan A, Seward J. The Incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factors Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2000. The 37th National Immunization Conference of CDC, March 19. 2003,","journal-title":"The 37th National Immunization Conference of CDC, March 19"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002","volume":"191","author":"Jumaan AO","year":"2005","unstructured":"Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005, 191:2002-7. 10.1086\/430325","journal-title":"J Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1086\/430328","article-title":"Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination","volume":"191","author":"Whitley RJ","year":"2005","unstructured":"Whitley RJ. Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination. J Infect Dis. 2005, 191:1999-2001. 10.1086\/430328","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2014.19.41.20926","article-title":"Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012","volume":"19","author":"Kelly HA","year":"2014","unstructured":"Kelly HA, Grant KA, Gidding H, Carville KS. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill. 2014, 19:10.2807\/1560-7917.es2014.19.41.20926","journal-title":"Euro Surveill"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn BP","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007, 82:1341-9. 10.4065\/82.11.1341","journal-title":"Mayo Clin Proc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4037","article-title":"Epidemiology of pediatric herpes zoster after varicella infection: a population-based study","volume":"135","author":"Wen SY","year":"2015","unstructured":"Wen SY, Liu WL. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study. Pediatrics. 2015, 135:e565-71. 10.1542\/peds.2013-4037","journal-title":"Pediatrics"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review","volume":"197 Suppl 2","author":"Reynolds MA","year":"2008","unstructured":"Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis. 2008, 197 Suppl 2:S224-7. 10.1086\/522162","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino MW","year":"1982","unstructured":"Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982, 61:310-6. 10.1097\/00005792-198209000-00003","journal-title":"Medicine (Baltimore)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai K","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R.  Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016, 63:221-6. 10.1093\/cid\/ciw296","journal-title":"Clin Infect Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz R","year":"2019","unstructured":"Harpaz R. Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States. Expert Rev Vaccines. 2019, 18:793-811. 10.1080\/14760584.2019.1646129","journal-title":"Expert Rev Vaccines"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy954","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among children","volume":"69","author":"Harpaz R","year":"2019","unstructured":"Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among children. Clin Infect Dis. 2019, 69:345-7. 10.1093\/cid\/ciy954","journal-title":"Clin Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy953","article-title":"The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults","volume":"69","author":"Harpaz R","year":"2019","unstructured":"Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019, 69:341-4. 10.1093\/cid\/ciy953","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy418","article-title":"Point-counterpoint: the Hope-Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence","volume":"218","author":"Harpaz R","year":"2018","unstructured":"Harpaz R, van Hoek AJ. Point-counterpoint: the Hope-Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence. J Infect Dis. 2018, 218:S57-62. 10.1093\/infdis\/jiy418","journal-title":"J Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0695-y","article-title":"Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review","volume":"19","author":"Prada-Ramallal G","year":"2019","unstructured":"Prada-Ramallal G, Takkouche B, Figueiras A. Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review. BMC Med Res Methodol. 2019, 19:53. 10.1186\/s12874-019-0695-y","journal-title":"BMC Med Res Methodol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000823","article-title":"Potentials, challenges, and limitations of the analysis of administrative data on vascular limb amputations in health care","volume":"49","author":"Kolossv\u00e1ry E","year":"2020","unstructured":"Kolossv\u00e1ry E, Ferenci T, Kov\u00e1ts T. Potentials, challenges, and limitations of the analysis of administrative data on vascular limb amputations in health care. Vasa. 2020, 49:87-97. 10.1024\/0301-1526\/a000823","journal-title":"Vasa"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz305","article-title":"The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991-2016","volume":"70","author":"Wolfson LJ","year":"2020","unstructured":"Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W. The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991-2016. Clin Infect Dis. 2020, 70:995-1002. 10.1093\/cid\/ciz305","journal-title":"Clin Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005","volume":"197 Suppl 2","author":"Chaves SS","year":"2008","unstructured":"Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis. 2008, 197 Suppl 2:S170-7. 10.1086\/522161","journal-title":"J Infect Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197 Suppl 2","author":"Galea SA","year":"2008","unstructured":"Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008, 197 Suppl 2:S165-9. 10.1086\/522125","journal-title":"J Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66053-insights-on-the-impact-of-external-and-internal-boosting-on-varicella-zoster-virus-reactivation-based-on-evidence-from-the-first-decade-of-the-united-states-universal-varicella-vaccination-program","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:23Z","timestamp":1707507203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66053-insights-on-the-impact-of-external-and-internal-boosting-on-varicella-zoster-virus-reactivation-based-on-evidence-from-the-first-decade-of-the-united-states-universal-varicella-vaccination-program"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.16963","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}